Sarcopenia en enfermedad pulmonar obstructiva crónica: rehabilitación pulmonar como factor fundamental en el tratamiento multidimensional de los adultos mayores

Sarcopenia in COPD: pulmonary rehabilitation as a fundamental factor in multidimensional treatment

Contenido principal del artículo

Miguel Germán Borda, MD.
Rodrigo Heredia, MD.


Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Miguel Germán Borda, MD., Pontificia Universidad Javeriana, Hospital Universitario San Ignacio. Bogotá, Colombia.

Residente de Primer año de Geriatría, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio. Bogotá, Colombia.

Rodrigo Heredia, MD., Hospital Universitario San Ignacio, Pontificia Universidad Javeriana. Bogotá, Colombia.

Médico Geriatra, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana. Bogotá, Colombia.

Referencias (VER)

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010;39:412-23.

Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70:213-8.

Goldstein G, Shelly C. Does the right hemisphere age more rapidly than the left? J Clin Neuropsychol. 1981;3:65-78.

Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Resp Crit Care Med. 1995;152:1268-74.

Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2002:Cd003793.

Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2807-13.

Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respiratory Med. 2000;94:859-67.

Samper-Ternet R, Reyes-Ortiz C, Ottenbacherc K, Cano C. Frailty and Sarcopenia in Colombia: Results from the SABE Bogotá Study 2014.

Marcell TJ. Sarcopenia: causes, consequences, and preventions. JGerontolA BiolSciMedSci. 2003;58:M911-M6.

Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27:337-9.

Rolland Y, Czerwinski S, Abellan VK, Morley JE, Cesari M, Onder G,

et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J NutrHealth Aging. 2008;12:433-50.

Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax.


Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 995;151:374-7.

Citado por